Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 7Mitoxantrone 5fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Etoposide 3Cyclophosphamide 3Busulfan 3Vorinostat 2Tacrolimus 2Methotrexate 2Idarubicin 2Decitabine 2Bortezomib 2tanespimycin 1ixazomib 1fludarabine 1entinostat 1eltrombopag 1choline magnesium trisalicylate 1alvocidib 1Whole-Body Irradiation 1Thiotepa 1Sorafenib 1Proteasome Inhibitors 1Pravastatin 1Mycophenolic Acid 1Metformin 1Lenalidomide 1Immunologic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Megakaryoblastic, Acute × Cytogenetic Analysis × Clear all
NCT00814164 2016-08-17

Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Roswell Park Cancer Institute

Phase 2 Terminated
21 enrolled 8 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡